Funding Rounds
Kither Biotech Series B (2022, $20M)
Kither BiotechPharmaceutical developer specializing in new treatments for chronic inflammatory diseases.
Summary
Stage: Series B
Raised Amount: $20.37M
Raised Date: 2022-01-01
Stage: Series B
Raised Amount: $20.37M
Raised Date: 2022-01-01
